Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Mark Mallon
Age : 57
Public asset : 8,874,810 USD
Country of residence : Unknown
Linked companies : NeoGenomics, Inc.

Biography of Mark Mallon 
Mr. Mark Mallon is a Chief Executive Officer & Director at NeoGenomics Laboratories, Inc. and a Chief Executive Officer & Director at NeoGenomics, Inc. He is on the Board of Directors at NeoGenomics Laboratories, Inc. and NeoGenomics, Inc. Mr. Mallon was previously employed as a Chief Executive Officer & Director by Ironwood Pharmaceuticals, Inc., a President by Astrazeneca China Ltd., a Chief Operating Officer by Astrazeneca Japan Ltd., a Vice President-Marketing & Sales Operations by AstraZeneca Pharmaceuticals LP, and an Executive Vice President-International by AstraZeneca Plc. He also served on the board at Christiana Care Corp. He received his undergraduate degree from the University of Pennsylvania and an MBA from The Wharton School of the University of Pennsylvania.


Current positions of Mark Mallon 
Holdings of Mark Mallon 
Mark Mallon : Personal Network 
Most Read News 
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/08MICHAEL O'LEARY : Exclusive-Ryanair ready to wait years for Boeing to cut prices, says O'Leary
RE
More news


© 2021 People and Ownership :   
Mark Mallon : Connections 


Latest news about Mark Mallon 
06/18NeoGenomics Laboratories, Inc. completed the acquisition of remaining 88.95% stake in Inivata Limited from a group of sellers.
CI
05/05NeoGenomics Laboratories, Inc. agreed to acquire remaining 88.95% stake in Inivata Limited from a group of sellers for $390 million.
CI
03/01NeoGenomics, Inc. Announces Chief Executive Officer Changes
CI
02/24NEOGENOMICS : Posts Higher Q4 Adjusted Earnings, Revenue; Names New CEO
MT
02/09IRONWOOD PHARMACEUTICALS : CEO to Step Down
MT
02/08Ironwood Pharmaceuticals, Inc. Announces CEO Transition
CI
02/08Ironwood Pharmaceuticals, Inc. Announces Board Changes
CI
More news